Zacks Investment Research lowered shares of Addus Homecare (NASDAQ:ADUS) from a hold rating to a sell rating in a research report report published on Thursday morning, Zacks.com reports.

According to Zacks, “ADDUS HOMECARE is a comprehensive provider of a broad range of social and medical services in the home. The company’s services include personal care and assistance with activities of daily living, skilled nursing and rehabilitative therapies, and adult day care. Its consumers are individuals with special needs who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Its payor clients include federal, state and local governmental agencies, the Veterans Health Administration, commercial insurers and private individuals. Addus operates its business through two divisions, home & community services and home health services. The home & community services are social, or non-medical, in nature and include assistance with bathing, grooming, dressing, personal hygiene and medication reminders, and other activities of daily living whereas the home health services are medical in nature and include physical, occupational and speech therapy, as well as skilled nursing. “

Other research analysts have also issued research reports about the company. BMO Capital Markets set a $85.00 target price on Addus Homecare and gave the company a hold rating in a report on Wednesday, August 7th. Raymond James set a $92.00 target price on Addus Homecare and gave the company an outperform rating in a report on Wednesday, August 7th. Sidoti set a $115.00 target price on Addus Homecare and gave the company a buy rating in a report on Wednesday, August 21st. Oppenheimer boosted their target price on Addus Homecare from $80.00 to $91.00 and gave the company a buy rating in a report on Wednesday, August 7th. Finally, William Blair reissued an outperform rating on shares of Addus Homecare in a report on Friday, August 9th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. The stock currently has a consensus rating of Buy and a consensus target price of $88.29.

Shares of NASDAQ:ADUS traded down $0.56 during trading on Thursday, reaching $78.10. The company had a trading volume of 197,479 shares, compared to its average volume of 234,155. The firm has a market capitalization of $1.21 billion, a price-to-earnings ratio of 46.21, a price-to-earnings-growth ratio of 2.49 and a beta of -0.10. The company has a debt-to-equity ratio of 0.17, a current ratio of 2.84 and a quick ratio of 2.84. The stock’s fifty day moving average price is $83.76 and its 200 day moving average price is $72.77. Addus Homecare has a fifty-two week low of $57.94 and a fifty-two week high of $92.91.

Addus Homecare (NASDAQ:ADUS) last released its earnings results on Monday, August 5th. The company reported $0.47 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.47. The business had revenue of $149.69 million for the quarter, compared to analyst estimates of $146.66 million. Addus Homecare had a return on equity of 8.55% and a net margin of 3.31%. On average, equities analysts anticipate that Addus Homecare will post 1.98 EPS for the current fiscal year.

In related news, insider W Bradley Bickham sold 15,000 shares of Addus Homecare stock in a transaction that occurred on Thursday, August 8th. The stock was sold at an average price of $80.67, for a total value of $1,210,050.00. Following the sale, the insider now directly owns 38,311 shares in the company, valued at $3,090,548.37. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Laurie Manning sold 990 shares of Addus Homecare stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $83.21, for a total value of $82,377.90. The disclosure for this sale can be found here. 20.10% of the stock is owned by insiders.

Institutional investors have recently bought and sold shares of the stock. BNP Paribas Arbitrage SA boosted its position in Addus Homecare by 9,077.3% during the first quarter. BNP Paribas Arbitrage SA now owns 2,019 shares of the company’s stock worth $128,000 after purchasing an additional 1,997 shares in the last quarter. Bank of Montreal Can boosted its position in Addus Homecare by 58.9% during the first quarter. Bank of Montreal Can now owns 545 shares of the company’s stock worth $35,000 after purchasing an additional 202 shares in the last quarter. SG Americas Securities LLC boosted its position in Addus Homecare by 108.8% during the first quarter. SG Americas Securities LLC now owns 4,652 shares of the company’s stock worth $296,000 after purchasing an additional 2,424 shares in the last quarter. Comerica Bank boosted its position in Addus Homecare by 3.0% during the first quarter. Comerica Bank now owns 9,951 shares of the company’s stock worth $652,000 after purchasing an additional 290 shares in the last quarter. Finally, Texas Permanent School Fund boosted its position in Addus Homecare by 3.8% during the first quarter. Texas Permanent School Fund now owns 6,848 shares of the company’s stock worth $435,000 after purchasing an additional 248 shares in the last quarter. Hedge funds and other institutional investors own 99.71% of the company’s stock.

About Addus Homecare

Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living.

See Also: Straddles

Get a free copy of the Zacks research report on Addus Homecare (ADUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Addus Homecare (NASDAQ:ADUS)

Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.